Vivo Bio Tech Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 129.2 million compared to INR 118.75 million a year ago. Revenue was INR 129.2 million compared to INR 118.75 million a year ago. Net income was INR 13.72 million compared to INR 22.28 million a year ago. Basic earnings per share from continuing operations was INR 0.97 compared to INR 1.73 a year ago. Diluted earnings per share from continuing operations was INR 0.93 compared to INR 1.7 a year ago.
For the nine months, sales was INR 360.86 million compared to INR 356.94 million a year ago. Revenue was INR 363.37 million compared to INR 356.94 million a year ago. Net income was INR 28.89 million compared to INR 53.85 million a year ago. Basic earnings per share from continuing operations was INR 2.03 compared to INR 4.18 a year ago. Diluted earnings per share from continuing operations was INR 1.95 compared to INR 4.12 a year ago.